vs

Side-by-side financial comparison of MEDIFAST INC (MED) and MARINE PRODUCTS CORP (MPX). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $64.6M, roughly 1.2× MARINE PRODUCTS CORP). On growth, MARINE PRODUCTS CORP posted the faster year-over-year revenue change (35.0% vs -36.9%). MARINE PRODUCTS CORP produced more free cash flow last quarter ($4.1M vs $-6.6M). Over the past eight quarters, MARINE PRODUCTS CORP's revenue compounded faster (-3.5% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

West Marine is an American company based in Fort Lauderdale, Florida, which operates a chain of boating supply and fishing retail stores. The company has 247 retail stores in North America. West Marine also runs Blue Future a non profit organization. West Marine's flagship store is in Fort Lauderdale. Opened on November 11, 2011, the store is the company's largest at over 50,000 square feet.

MED vs MPX — Head-to-Head

Bigger by revenue
MED
MED
1.2× larger
MED
$75.1M
$64.6M
MPX
Growing faster (revenue YoY)
MPX
MPX
+71.9% gap
MPX
35.0%
-36.9%
MED
More free cash flow
MPX
MPX
$10.8M more FCF
MPX
$4.1M
$-6.6M
MED
Faster 2-yr revenue CAGR
MPX
MPX
Annualised
MPX
-3.5%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
MPX
MPX
Revenue
$75.1M
$64.6M
Net Profit
$2.4M
Gross Margin
69.4%
19.6%
Operating Margin
-10.4%
5.8%
Net Margin
3.7%
Revenue YoY
-36.9%
35.0%
Net Profit YoY
-44.6%
EPS (diluted)
$-1.64
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
MPX
MPX
Q4 25
$75.1M
$64.6M
Q3 25
$89.4M
$53.1M
Q2 25
$105.6M
$67.7M
Q1 25
$115.7M
$59.0M
Q4 24
$119.0M
$47.8M
Q3 24
$140.2M
$49.9M
Q2 24
$168.6M
$69.5M
Q1 24
$174.7M
$69.3M
Net Profit
MED
MED
MPX
MPX
Q4 25
$2.4M
Q3 25
$-2.3M
$2.6M
Q2 25
$2.5M
$4.2M
Q1 25
$-772.0K
$2.2M
Q4 24
$4.3M
Q3 24
$1.1M
$3.4M
Q2 24
$-8.2M
$5.6M
Q1 24
$8.3M
$4.6M
Gross Margin
MED
MED
MPX
MPX
Q4 25
69.4%
19.6%
Q3 25
69.5%
19.2%
Q2 25
72.6%
19.1%
Q1 25
72.8%
18.6%
Q4 24
74.1%
19.2%
Q3 24
75.4%
18.4%
Q2 24
73.2%
18.9%
Q1 24
72.8%
20.2%
Operating Margin
MED
MED
MPX
MPX
Q4 25
-10.4%
5.8%
Q3 25
-4.6%
5.4%
Q2 25
-1.0%
7.1%
Q1 25
-1.1%
4.4%
Q4 24
0.6%
7.7%
Q3 24
1.5%
7.2%
Q2 24
-4.7%
8.3%
Q1 24
4.5%
7.6%
Net Margin
MED
MED
MPX
MPX
Q4 25
3.7%
Q3 25
-2.5%
5.0%
Q2 25
2.3%
6.1%
Q1 25
-0.7%
3.7%
Q4 24
8.9%
Q3 24
0.8%
6.8%
Q2 24
-4.8%
8.0%
Q1 24
4.8%
6.6%
EPS (diluted)
MED
MED
MPX
MPX
Q4 25
$-1.64
$0.07
Q3 25
$-0.21
$0.07
Q2 25
$0.22
$0.12
Q1 25
$-0.07
$0.06
Q4 24
$0.08
$0.13
Q3 24
$0.10
$0.10
Q2 24
$-0.75
$0.14
Q1 24
$0.76
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
MPX
MPX
Cash + ST InvestmentsLiquidity on hand
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$125.0M
Total Assets
$248.0M
$147.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
MPX
MPX
Q4 25
$167.3M
Q3 25
$173.5M
Q2 25
$162.7M
Q1 25
$164.6M
Q4 24
$162.3M
Q3 24
$170.0M
Q2 24
$163.5M
Q1 24
$156.4M
Stockholders' Equity
MED
MED
MPX
MPX
Q4 25
$198.9M
$125.0M
Q3 25
$214.7M
$126.3M
Q2 25
$216.0M
$127.2M
Q1 25
$211.0M
$126.4M
Q4 24
$210.1M
$129.0M
Q3 24
$207.3M
$128.8M
Q2 24
$205.3M
$129.3M
Q1 24
$211.0M
$151.4M
Total Assets
MED
MED
MPX
MPX
Q4 25
$248.0M
$147.2M
Q3 25
$268.2M
$179.5M
Q2 25
$269.3M
$173.2M
Q1 25
$280.0M
$182.9M
Q4 24
$284.2M
$171.2M
Q3 24
$291.2M
$176.3M
Q2 24
$293.5M
$175.7M
Q1 24
$302.8M
$204.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
MPX
MPX
Operating Cash FlowLast quarter
$-5.3M
$4.7M
Free Cash FlowOCF − Capex
$-6.6M
$4.1M
FCF MarginFCF / Revenue
-8.8%
6.4%
Capex IntensityCapex / Revenue
1.8%
0.9%
Cash ConversionOCF / Net Profit
2.00×
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$14.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
MPX
MPX
Q4 25
$-5.3M
$4.7M
Q3 25
$12.1M
$2.6M
Q2 25
$-3.4M
$-1.6M
Q1 25
$3.4M
$10.8M
Q4 24
$-4.9M
$4.6M
Q3 24
$9.1M
$5.1M
Q2 24
$13.1M
$3.8M
Q1 24
$7.3M
$15.9M
Free Cash Flow
MED
MED
MPX
MPX
Q4 25
$-6.6M
$4.1M
Q3 25
$10.8M
$2.1M
Q2 25
$-4.8M
$-2.0M
Q1 25
$1.9M
$10.7M
Q4 24
$-7.2M
$3.6M
Q3 24
$7.7M
$3.2M
Q2 24
$11.1M
$3.0M
Q1 24
$5.4M
$15.0M
FCF Margin
MED
MED
MPX
MPX
Q4 25
-8.8%
6.4%
Q3 25
12.0%
4.0%
Q2 25
-4.5%
-3.0%
Q1 25
1.6%
18.1%
Q4 24
-6.1%
7.6%
Q3 24
5.5%
6.5%
Q2 24
6.6%
4.4%
Q1 24
3.1%
21.7%
Capex Intensity
MED
MED
MPX
MPX
Q4 25
1.8%
0.9%
Q3 25
1.5%
0.8%
Q2 25
1.3%
0.6%
Q1 25
1.3%
0.2%
Q4 24
1.9%
2.1%
Q3 24
1.0%
3.8%
Q2 24
1.1%
1.1%
Q1 24
1.1%
1.3%
Cash Conversion
MED
MED
MPX
MPX
Q4 25
2.00×
Q3 25
0.97×
Q2 25
-1.36×
-0.39×
Q1 25
4.88×
Q4 24
1.09×
Q3 24
8.04×
1.51×
Q2 24
0.68×
Q1 24
0.88×
3.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

MPX
MPX

Boats And Accessories$63.4M98%
Parts$1.1M2%

Related Comparisons